• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Morgan Stanley & Co. LLC

	Start	2016-02-08 existent
	Group	Morgan Stanley (Group)
	Industry	investment banking
	Region	New York, NY
	Country	United States (USA)
		Record changed: 2019-03-17

Advertisement

More documents for Morgan Stanley (Group)

• [1] Galapagos N.V.. (9/13/18). "Press Release: Galapagos Raises $300 Million Gross Proceeds in a U.S. Public Offering". Mechelen....
• [2] Galapagos N.V.. (9/12/18). "Press Release: Galapagos Announces Launch of Proposed Public Offering". Mechelen....
• [3] Bruker Corporation. (9/7/18). "Press Release: Bruker Corporation to Present at the 16th Annual Morgan Stanley Global Healthcare Conference". Billerica, MA....
• [4] Thermo Fisher Scientific Inc.. (9/4/18). "Press Release: Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2018". Waltham, MA....
• [5] Nabriva Therapeutics plc. (7/26/18). "Press Release: Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $50 Million". Dublin & King of Prussia, PA....
• [6] Nabriva Therapeutics plc. (7/25/18). "Press Release: Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares". Dublin & King of Prussia, PA....
• [7] DBV Technologies S.A.. (3/26/18). "Press Release: DBV Technologies Announces Closing of Underwriters’ Option to Purchase Additional Shares in Global Offering". Montrouge....
• [8] DBV Technologies S.A.. (3/23/18). "Press Release: DBV Technologies Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Montrouge....
• [9] DBV Technologies S.A.. (3/20/18). "Press Release: DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares". Montrouge....
• [10] Nabriva Therapeutics plc. (9/19/17). "Press Release: Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $80 Million". Dublin & King of Prussia, PA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.